Benfotiamine increases transketolase activity, that can, in turn, decreases the buildup of detrimental glucose metabolites that can lead to advanced glycation end products (AGE), which may lead to diabetic complications. Benfotiamine also prevents diabetic retinopathy. Benfotiamine and alpha-lipoic acid should be considered as first choices among pathogenetically oriented treatments of diabetic neuropathy. Chromium and Inositol improve glucose metabolism & enhances muscle insulin sensitivity.
How to use
Use as directed by the physician
Interactions / Warnings
Use under medical supervision.
Uses / Indications
Prevent diabetic retinopathy, Prevent diabtetic neuropathy and imporove glucose metabolism.
